Hospital
Mary Greeley Medical Center
Mary Greeley Medical Center was paid $9.11M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoMARY GREELEY MEDICAL CENTER
AMES, IA 50010
AMES, IA 50010
33aNPI1477539492assigned 12/21/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.11M
24GClaims204,091
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Iowa
Rank by total paid#14 of 29
Median peer was paid$6.37M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,002 | $1.06M | |
| 2019 | 24,858 | $1.35M | |
| 2020 | 21,509 | $1.29M | |
| 2021 | 38,541 | $1.61M | |
| 2022 | 41,882 | $1.40M | |
| 2023 | 34,021 | $1.46M | |
| 2024incomplete | 21,278 | $943K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 21,660 | 20,450 | $2.98M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 12,391 | 11,528 | $2.70M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10% | 9,616 | 8,898 | $923K |
| A0999 | Unlisted ambulance service | 6.3% | 694 | 501 | $571K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.9% | 5,507 | 5,203 | $447K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 705 | 653 | $359K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 4,255 | 3,853 | $226K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.6% | 160 | 159 | $144K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 3,023 | 2,843 | $103K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,493 | 1,390 | $82K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 650 | 514 | $56K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | <1% | 797 | 638 | $56K |
70 more codes
| A0427 | Emergency ambulance ride, advanced life support | <1% | 666 | $55K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,712 | $54K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 305 | $53K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,174 | $50K |
| 71045 | Radiologic examination, chest; single view | <1% | 934 | $47K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 529 | $39K |
| A0425 | Ground mileage, per statute mile | <1% | 2,116 | $33K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 303 | $29K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,482 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 238 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 337 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 152 | $15K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,060 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 238 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 24,127 | $4K |
| 80076 | <1% | 18,975 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,609 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,116 | $2K |
| 94060 | <1% | 13 | $2K | |
| 93296 | <1% | 109 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $2K |
| 83690 | <1% | 3,619 | $1K | |
| 84484 | <1% | 2,332 | $961.49 | |
| 83735 | <1% | 1,262 | $948.33 | |
| 87631 | <1% | 2,108 | $683.52 | |
| 81001 | <1% | 6,293 | $561.05 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 589 | $520.74 |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,428 | $467.91 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $435.40 |
| 87632 | <1% | 305 | $418.46 | |
| 87581 | <1% | 2,468 | $318.97 | |
| 81025 | <1% | 2,253 | $273.85 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,048 | $249.90 |
| 86140 | <1% | 1,070 | $154.27 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $153.01 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 30 | $137.08 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 13 | $128.67 |
| 81003 | <1% | 1,507 | $93.39 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 722 | $89.99 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 538 | $70.18 |
| 83605 | <1% | 200 | $64.82 | |
| 85730 | <1% | 252 | $38.48 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 577 | $28.17 |
| 85610 | <1% | 371 | $25.99 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 169 | $18.41 |
| 80306 | <1% | 539 | $16.44 | |
| 82150 | <1% | 39 | $2.66 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 341 | $0.46 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,309 | $0.36 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 284 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,984 | $0.00 |
| 94726 | 0% | 13 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 66 | $0.00 |
| 94729 | 0% | 13 | $0.00 | |
| 84702 | 0% | 12 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 52 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,541 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 234 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 349 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 489 | $0.00 |
| 87040 | 0% | 23 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 80 | $0.00 |
| 85652 | 0% | 16 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 61 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 27 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 80 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 97 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 15 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 47 | $0.00 |
| 85379 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEARDORFF, AMBER (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Mary Greeley Medical Center | Ames, IA | $4.39M |
| Mary Greeley Medical Center | Ames, IA | $405K |
| Mary Greeley Medical Center | Ames, IA | $91K |
| Mary Greeley Medical Center | Ames, IA | $80K |
| Mary Greeley Medical Center | Ames, IA | $63K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.